Nagpur: As the festive season begins, city doctors are reporting a steady rise in H3N2 influenza and Respiratory Syncytial ...

The number of CT machines in Israel is limited, and waiting times can be long. An AI–based system has succeeded in shortening ...

Scientists at the Francis Crick Institute have developed a new cancer therapy that halts tumour growth without harming healthy cells, now entering human trials.

Seven Roman soldiers' remains found in a Croatian well may be tied to the 260 CE Battle of Mursa, revealing brutal deaths ...

Johnson & Johnson (NYSE:JNJ) today announced promising new results from the Phase 1b/2 OrigAMI-4 study evaluating the efficacy and safety of subcutaneous (SC) amivantamab monotherapy in patients with ...

After upstaging Merck & Co.’s Keytruda as a monotherapy for patients with first-line non-small cell lung cancer (NSCLC) in ...

GSK may be happy with the latest readouts from two Hansoh-partnered antibody-drug conjugates (ADCs), but the Big Pharma’s ...

Patients with advanced lung or skin cancer who received a COVID-19 mRNA vaccine within 100 days of starting immunotherapy ...

BRAFTOVI + MEKTOVI continued to show a substantial median overall survival benefit of 47.6 months in treatment-naïve patients with BRAF V600E-mutant metastatic non-small cell lung cancer after ...

Researchers at the Francis Crick Institute and Vividion Therapeutics have developed a new compound that stops cancer growth ...

Tubulis’ next-generation antibody-drug conjugate (ADC) has been tied to an overall response rate (ORR) of 59% as the German ...

Scientists have found a new way to stop cancer growth without damaging healthy cells. Researchers from the Francis Crick Institute and Vividion Therapeutics discovered a compound that blocks the ...